Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

Clinical trial NCT00132314 · COMPLETED

Trial details

NCT number: NCT00132314
Sponsor: US Department of Veterans Affairs
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizoaffective Disorder Schizophrenia

Start date: 2006-09-01
Primary completion: 2009-09-01
Enrollment: 382

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.